12-48997618-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_015086.2(DDN):c.1258G>A(p.Glu420Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000515 in 1,553,550 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015086.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DDN | NM_015086.2 | c.1258G>A | p.Glu420Lys | missense_variant | 2/2 | ENST00000421952.3 | NP_055901.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DDN | ENST00000421952.3 | c.1258G>A | p.Glu420Lys | missense_variant | 2/2 | 1 | NM_015086.2 | ENSP00000390590.2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152282Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000198 AC: 4AN: 202234Hom.: 0 AF XY: 0.0000186 AC XY: 2AN XY: 107670
GnomAD4 exome AF: 0.00000428 AC: 6AN: 1401268Hom.: 0 Cov.: 34 AF XY: 0.00000290 AC XY: 2AN XY: 690448
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152282Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74404
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 17, 2024 | The c.1258G>A (p.E420K) alteration is located in exon 2 (coding exon 2) of the DDN gene. This alteration results from a G to A substitution at nucleotide position 1258, causing the glutamic acid (E) at amino acid position 420 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at